Form D — RECODE THERAPEUTICS, INC.
0000905148-25-003655 · filed 2025-10-23
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $29,441,931
- Total sold
- $29,441,931
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- RECODE THERAPEUTICS, INC.
- CIK
- 1693764
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1140 O'Brien Drive
Menlo Park, CA 94025 - Phone
- 408-585-1700
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shehnaaz Suliman · Executive OfficerMenlo Park, CA Find on LinkedIn ↗
-
Peter A. Thompson · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Helen S. Kim · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Edward Hurwitz · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Rana Al-Hallaq · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Rakhshita Dhar · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Alan Colowick · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Patricia Millican · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Dean Mitchell · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Inai Park · DirectorMenlo Park, CA Find on LinkedIn ↗
-
Basheer Zada · DirectorMenlo Park, CA Find on LinkedIn ↗
-
David Lockhart · Executive OfficerMenlo Park, CA Find on LinkedIn ↗
View original on SEC EDGAR.